The Patent Finder

Symphogen A/S

Also on record
Records under this name other than the patents Symphogen A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Symphogen A/S

PatentTitleStatus Expires Confidence
US 8,414,896Recombinant anti-epidermal growth factor receptor antibody compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,887,805Recombinant anti-epidermal growth factor receptor antibody compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,283,294Method for cloning cognate antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,663,640Methods using recombinant anti-epidermal growth factor receptor antibody compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,450,376Anti-MET antibodies and compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,034,765ANTI-PD-1 Antibodies and Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,834,503ANTI-LAG-3 Antibodies and Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,359,018Anti-PD-1 Antibodies and Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,030,942Anti-PD-1 antibodies and compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,390,674ANTI-TIM-3 Antibodies and Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 32 patents shown.
Pro members see all 32.
Pro members: see all 32 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited